Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.
与去岩藻糖基化的抗 HM1.24 单克隆抗体和来那度胺联合使用，可诱导针对骨髓瘤细胞及其祖细胞的显著 ADCC
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0083905
Harada Takeshi, Ozaki Shuji, Oda Asuka, Tsuji Daisuke, Ikegame Akishige, Iwasa Masami, Udaka Kengo, Fujii Shiro, Nakamura Shingen, Miki Hirokazu, Kagawa Kumiko, Kuroda Yoshiaki, Kawai Shigeto, Itoh Kohji, Yamada-Okabe Hisafumi, Matsumoto Toshio, Abe Masahiro
